Trials / Recruiting
RecruitingNCT05864456
Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study
Evaluation of the Safety and Efficacy of the Prizvalve Pro™ Transcatheter Aortic Valve System in the Treatment of Patients With Severe Aortic Valve Stenosis Disease at High Surgical Risk
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (estimated)
- Sponsor
- Shanghai NewMed Medical Co., Ltd. · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to evaluate the safety and efficacy of the Prizvalve Pro™ transcatheter aortic valve system in the treatment of patients with severe aortic stenosis who are at high risk of surgery or who are not suitable for surgery.
Detailed description
This study is a multicenter, single-arm, prospective clinical study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Prizvalve Pro™ transcatheter aortic valve system | Transcatheter Aortic Valve Replacement |
Timeline
- Start date
- 2023-07-05
- Primary completion
- 2024-06-01
- Completion
- 2028-05-01
- First posted
- 2023-05-18
- Last updated
- 2023-11-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05864456. Inclusion in this directory is not an endorsement.